Manufacturing Depression: the placebo story
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Dr. Larry Kaskel is joined by psychotherapist and freelance journalist Dr. Gary Greenberg who participated in a clinical trial for a new anti-depression medication. He discusses the fact that in over half the trials used to approve the six leading anti-depressants, the drugs failed to outperform the placebo. He also speaks about the discovery of a pattern of brain activity that is common to those subjects who respond to the placebo.
Overview
Dr. Larry Kaskel is joined by psychotherapist and freelance journalist Dr. Gary Greenberg who participated in a clinical trial for a new anti-depression medication. He discusses the fact that in over half the trials used to approve the six leading anti-depressants, the drugs failed to outperform the placebo. He also speaks about the discovery of a pattern of brain activity that is common to those subjects who respond to the placebo.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
IgG4-RD Case Conversations: IgG4-related Autoimmune Pancreatitis and Cholangitis
Updates From the 7th World Symposium Task Force
Diagnosis and Management of Metastatic PDAC
New Horizons: Unraveling Novel Therapies for Enhanced Cardiovascular Outcomes in Patients With Heart Failure
Partnering with Patients: Building Effective Communication and Support in HF Care
A Practical Guide to Prescribing in HF
Clinical Conundrums in ARIA: Nuances of Microhemorrhages when Evaluating an MRI for ARIA
Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?